文献速递神经肿瘤

磁共振成像技术监测胶质瘤对放化疗反应

Magnetic resonance imaging techniques for monitoring glioma response to chemoradiotherapy.
PubMed 文献 · J Neurooncol · 2024-11-11

本叙述性综述回顾了灌注MRI、弥散加权成像、定量磁化传递成像和化学交换转移MRI在胶质瘤早期治疗反应评估中的历史与现状。化学交换饱和转移成像可能最早检测代谢变化,弥散加权成像对放疗中后期肿瘤细胞密度变化敏感且可预测无进展生存和总生存,灌注MRI可鉴别肿瘤复发与治疗效应但采集与判读缺乏共识,磁化传递成像显示检测白质损伤的潜力但需更多研究。

要点

  • 化学交换饱和转移成像可能最早检测胶质瘤治疗后的代谢变化。
  • 弥散加权成像对放疗中后期肿瘤细胞密度变化敏感,可预测无进展生存和总生存。
  • 各先进MRI技术单独应用缺乏特异性,多参数成像可能有助于生物学解释和治疗指导。

核心结论

  • 先进MRI技术对胶质瘤早期治疗反应评估有潜力,但每种技术单独应用缺乏特异性,多参数成像可能有助于生物学解释和治疗指导。

研究设计与样本

  • 叙述性综述,非正式系统综述,文献调查涵盖灌注MRI、弥散加权成像、定量磁化传递成像和化学交换转移MRI,选取各技术应用于胶质瘤治疗反应评估历史中的精选文章。

主要发现

  • 化学交换饱和转移成像可能最早检测肿瘤代谢变化导致的治疗反应。
  • 弥散加权成像对放疗中后期肿瘤细胞密度变化敏感,可预测无进展生存和总生存。
  • 大量证据提示灌注MRI可鉴别肿瘤复发与治疗效应,但采集、处理和判读方面仍缺乏共识。
  • 磁化传递成像显示检测提示肿瘤侵犯的细微白质损伤的潜力,但该领域需更多研究。

局限性

  • 本报告为叙述性综述,非正式系统综述。
  • 灌注MRI在采集、处理和判读方面仍缺乏共识。
  • 磁化传递成像检测细微白质损伤提示肿瘤侵犯的潜力需更多研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Treatment response assessment for gliomas currently uses changes in tumour size as measured with T1- and T2-weighted MRI. However, changes in tumour size may occur many weeks after therapy completion and are confounded by radiation treatment effects. Advanced MRI techniques sensitive to tumour physiology may provide complementary information to evaluate tumour response at early timepoints during therapy. The objective of this review is to provide a summary of the history and current knowledge regarding advanced MRI techniques for early treatment response evaluation in glioma. METHODS: The literature survey included perfusion MRI, diffusion-weighted imaging, quantitative magnetization transfer imaging, and chemical exchange transfer MRI. Select articles spanning the history of each technique as applied to treatment response evaluation in glioma were chosen. This report is a narrative review, not formally systematic. RESULTS: Chemical exchange saturation transfer imaging potentially offers the earliest method to detect tumour response due to changes in metabolism. Diffusion-weighted imaging is sensitive to changes in tumour cellularity later during radiotherapy and is prognostic for progression-free and overall survival. Substantial evidence suggests that perfusion MRI can differentiate between tumour recurrence and treatment effect, but consensus regarding acquisition, processing, and interpretation is still lacking. Magnetization transfer imaging shows promise for detecting subtle white matter damage which could indicate tumour invasion, but more research in this area is needed. CONCLUSION: Advanced MRI techniques show potential for early treatment response assessment, but each technique alone lacks specificity. Multiparametric imaging may be necessary to aid biological interpretation and enable treatment guidance.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Lawrence LSP, Maralani PJ, Das S, et al. Magnetic resonance imaging techniques for monitoring glioma response to chemoradiotherapy. J Neurooncol. 2024. PMID: 39527382. doi:10.1007/s11060-024-04856-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。